Skip to main content
Article
De-novo acute myeloid leukemia in a BRCA positive female with locally treated ductal carcinoma in situ
Leukemia research reports
  • Edward Nabrinsky, Advocate Aurora Health
  • Faisal Masood, Advocate Aurora Health
  • Sufyan Abdulmujeeb, Advocate Aurora Health
  • Nahren Asado, Advocate Aurora Health
  • Imad Almanaseer, Advocate Aurora Health
  • Angel Galvez, Advocate Aurora Health
Affiliations

Department of Internal Medicine, Advocate Lutheran General Hospital

Department of Pathology, Advocate Lutheran General Hospital

Department of Hematology and Oncology, Advocate Lutheran General Hospital

Publication Date
2-9-2021
Abstract

Acute myeloid leukemia (AML) is primarily a disease of older adults and can arise de novo, in relation to previous treatment or in the setting of underlying hematological disease. While it is known to arise from chemoradiation in the setting of breast cancer, little is known about the association between BRCA carriers and AML. We report a case of a young female BRCA carrier who develops de novo AML without prior chemoradiation treatment, and examine if there is a link between BRCA and developing leukemia.

Document Type
Article
PubMed ID
33665080
Citation Information

Nabrinsky E, Masood F, AbdulMujeeb S, Asado N, Almanaseer I, Galvez A. De-novo acute myeloid leukemia in a BRCA positive female with locally treated ductal carcinoma In Situ. Leuk Res Rep. 2021 Feb 9;15:100237. doi: 10.1016/j.lrr.2021.100237. PMID: 33665080; PMCID: PMC7902915